Freedom Leaf Inc., is a group of diversified, international, vertically-integrated hemp businesses and cannabis media companies. We are a fully-reporting and audited publicly-traded company under the symbol (OTCQB: FRLF). Freedom Leaf Inc. has been a leading go-to resource in the medical cannabis and industrial hemp industries since 2014, founded by professionals with decades of combined experience in cannabis and hemp legalization advocacy. FRLF is constantly striving to build a diverse portfolio of valuable businesses through strategic mergers, acquisitions, and acceleration projects across the industry.

FRLF’s large portfolio of acquisitions and properties includes: Our premier 430,000 sq. ft. European hemp cultivation and research operation Leafceuticals Europe S.L.U. The Company also owns and operates a fully-licensed 8,000 sq. ft. hemp extraction, distillation, and processing laboratory in Las Vegas, Nevada, licensed under Leafceuticals, Inc. The Company then formulates, markets, and distributes CBD-based health and wellness products under premium brand names Irie CBD and Hempology, which boast product lines with more than 30 high-quality hemp-derived CBD products. The Company additionally reaches ancillary tobacco product markets with our hemp-based rolling paper company, Plants to Paper. Market awareness, customer relationships, and distribution channels are reinforced in carefully-targeted demographic niches through The Company’s multiple global media properties, including: our newly renovated MarijuanaNews.com, the largest Spanish-language cannabis web portal in the world LaMarihuana.com, our Spanish medicine-based educational website Marihuana-Medicinal.com, and of course our flagship print and digital publication, Freedom Leaf Magazine. The Company also cross-markets via strategic investments in B2B and B2C channels such as Cicero Transact LLC and through international affiliate marketing programs under the Tierra Sciences Global brand.

Utilizing these mergers and acquisitions, Freedom Leaf Inc. is continually building a solid foundation for our vertically-integrated, global hemp corporation to maximize both shareholder value and revenue growth. Our cultivation and extraction divisions allow FRLF to grow and source our own hemp-derived CBD, which allows dramatically lower production costs for our wholly-owned hemp CBD product lines, thereby generating more revenue for each product sold. We also formulate and manufacture the majority of our products in our own in-house formulation centers, greatly reducing our costs and increasing revenue. In addition, our extensive domestic and international media entities ensure we can continuously direct high-volume traffic to our network of ecommerce sites and nationwide retail locations, and our partner companies in the affiliate marketing space help promote our products and brands to international markets. With our strategic plan of mergers and acquisitions, Freedom Leaf Inc. intends to become an industry leader in the rapidly-growing global hemp and cannabis industry.

Freedom Leaf Inc. also sells licenses to use the Freedom Leaf brand in different countries and states across the globe. We have entered into three license agreements: for Spain and Portugal, for The Netherlands, and for Florida.

 

Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana or related products.

All of our European activities are in full compliance with relevant EU laws.

Investor relations information can be found on the FreedomLeafInc.com company website.

 

Safe Harbor Statement

Statements on this site that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by phrases such as Freedom Leaf, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Factors that could cause or contribute to differences include the uncertainty regarding viability and market acceptance of the Company’s products and services, changes in relationships with third parties, and other factors described in the Company’s most recent periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K dated June 30, 2016 and quarterly reports on Form 10-Q.

 

Contact:

Raymond Medeiros
PR and Business Development Director
Phone: 415-601-1974
ray@freedomleaf.com
Freedom Leaf, Inc.